Acinetobacter spp. are Gram-negative bacteria that have become one of the most difficult
pathogens to treat. The species A. baumannii, largely unknown 30 years ago, has risen to …

We may soon be facing the end of the “antibiotic era.” The initial and seemingly unstoppable
success of antibiotics, the fruit of human ingenuity, has been countered by an escalation of …

Amid the recent attention focused on the growing impact of methicillin-resistant
Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa infections, the …

Despite having a reputation of low virulence, Acinetobacter baumannii is an emerging
multidrug-resistant (MDR) pathogen responsible for community-and hospital-acquired …

Multidrug-resistant Acinetobacter baumannii is recognized to be among the most difficult
antimicrobial-resistant gram-negative bacilli to control and treat. Increasing antimicrobial …

Carbapenem-resistant Acinetobacter baumannii (CRAB) are an increasing infectious threat
in hospitals. We investigated the clinical epidemiology of CRAB infections vs. colonization in …

Carbapenem-resistant Acinetobacter baumannii pose a significant threat to hospitalized
patients, as therapeutic options are scarse. Alarmingly, rates of carbapenem-resistance in A …

Multi-drug-resistant Acinetobacter baumannii isolates are key pathogens that contribute to
the global burden of antimicrobial resistance. This study aimed to investigate the phenotypic …

Objectives We have investigated the molecular epidemiology and distribution of
carbapenemase genes in 492 imipenem-non-susceptible Acinetobacter baumannii …

Acinetobacter baumannii, recognized as a serious threat in healthcare facilities, has the
ability to develop resistance to antibiotics quite easily. This resistance is related to either …